SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
JNJ Analysis & Videos »
JNJ: Bull or Bear?
Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth
JNJ
|
|
|
-1.02%
in
9 days
<>Filed under: Hewlett-Packard (HPQ), eBay (EBAY), Pfizer (PFE), Wal-Mart (WMT), International Business Machines (IBM), Johnson and Johnson (JNJ), JPMorgan Chase (JPM), Abbott Laboratories (ABT), AFLAC Inc (AFL), Altria Group (MO), Archer-Daniels-Midland (ADM), AutoZone Inc (AZO), Bristol-Myers Squibb (BMY), Campbell Soup (CPB), Chevron Corp (CVX), Chubb Corp (CB), ConocoPhillips (COP), CVS Corp (CVS), Darden Restaurants (DRI), Goldman Sachs Group (GS), General Mills (GIS), Verizon Communications (VZ), duPont(E.I.)deNemours (DD), Kimberly-Clark (KMB), Merck and Co (MRK), Lockheed Martin (LMT)...
|
Chasing Value: Ten stocks for 2010 -- Part 6
JNJ
|
|
|
-2.29%
in
56 days
(closed on 02/01/10)
Filed under: International markets, Management, Exxon Mobil (XOM), Johnson and Johnson (JNJ), Chasing Value, Stock screen, Oil, Stocks to Buy, Brown Forman (BF.A)  In Part 6, we're going back for seconds: our second alcohol company, energy company and medical company. The reasons should be apparent, but in case they aren't: I think all three are essential -- maybe alcohol more than the other two. Ironically alcohol can be substituted for the other two, and often has been.
<>All three companies are well-established and U.S. based, lead their respective industries, have top flight management in th...
|
Epinex Diagnostics: A New Paradigm for Diabetic Testing
JNJ
|
|
|
+0.08%
in
83 days
Epinex Diagnostics Inc. (click on preceding link for the Company's News Room page) is a private company that is dedicated to the development of innovative point-of-care technologies using rapid diagnostic tests. Epinex has developed a proprietary platform for rapid tests that apply existing immunoassay strips and biosensors to create unique quantitative diagnostic tests. Advantages of the Epinex Quantitative Immunoassay System for Point-of-Care Testing include the following: 1.) Rapid: Results within minutes. <> 2.) Quantitative: Yields a<><><><><><><>< /><><>< /><><><><><><><>< /><>< /><><><><><><><><><>...
|
Where should granny put $50,000?
JNJ
|
|
|
+4.45%
in
59 days
(closed on 12/07/09)
Filed under: Getting started, McDonald's (MCD), Diageo plc (DEO), Johnson and Johnson (JNJ), Altria Group (MO), Novartis AG ADS (NVS), Automatic Data Proc (ADP), Kellogg Co (K), Consolidated Edison (ED), General Mills (GIS), Procter and Gamble (PG), Merck and Co (MRK), Duke Energy (DUK), Personal finance, S and P 500, Stocks to Buy, Southern Company (SO), Annaly Capital Management (NLY) <> One of my wonderful friends, Ms. P, asked me for some guidance on how she might allocate $50,000 currently earning peanuts in a money market account. Though she is decades from becoming a grandmother, after a...
|
Cramer on BloggingStocks: You can't afford to be certain
JNJ
+1.99%
in
194 days
<>Filed under: Apple Inc (AAPL), Hewlett-Packard (HPQ), Ford Motor (F), Market matters, Walt Disney (DIS), International Business Machines (IBM), AT and T (T), 3M Corporation (MMM), Caterpillar (CAT), Schlumberger Limited (SLB), Citigroup Inc. (C), Johnson and Johnson (JNJ), JPMorgan Chase (JPM), Bank of America (BAC), Bed Bath and Beyond (BBBY), Best Buy (BBY), FedEx Corp (FDX), Verizon Communications (VZ), Lennar Corp'A' (LEN), United Parcel'B' (UPS), Anadarko Petroleum (APC), Wells Fargo (WFC), Stocks to Buy, Norfolk Southern Corp. (NSC), Union Pacific Corporation (UNP), <>Cramer on Blogging...
|
BioMedReports: FDA Calendar Updates
JNJ
|
|
|
+5.70%
in
127 days
(closed on 11/19/09)
<> Below is a summary of updates to the BioMedReports.com FDA Calendar , which includes a database of 260 entries as of 7/15/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage clini...
|
FDA Calendar Updates: ABII, BMRN, JNJ, OSIP, Roche
JNJ
|
|
|
+2.22%
in
2 days
(closed on 07/15/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 254 entries as of 7/13/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pendin...
|
FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News
JNJ
|
|
|
+3.24%
in
54 days
(closed on 07/13/09)
<> Below is a summary of updates to the <font> BioMedReports.com </font> database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA fo...
|
FDA Calendar Updates: ACUS, APPY, APPA, ALKS, JNJ
JNJ
|
|
|
-0.32%
in
2 days
(closed on 05/20/09)
<> Below is a summary of updates to the <font> BioMedReports.com </font> database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA fo...
|
People Bullish on JNJ
People Bearish on JNJ
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
|
|
|
|
fas831
(-8.21% risk: conservative)
|
|
Johnson & Johnson vs 3M
- I have been waiting and waiting for JNJ to drop but its really dissapointing seeing such a steady stock..on the other hand is 3M who is JNJ's competito
|
More Resources
|
About Johnson & Johnson
- Answers.com
"For our latest featured stock of the month, we have chosen Johnson & Johnson (
Billions of investment dollars are sitting on the sidelines for fear of entering the market at the wrong time and losing more money after taking a bath last year. However, the market seems to have hit bottom last March and many investors missed the 40% gain from that point to now.
Readers of this space know that the investment bias is toward large-cap companies with demonstrated business models, who have a competitive advantage in established markets, preferably with a favorable, global trend as a support. And with that in mind, 
